Effect of Omega3 in Treatment of Chronic Urticaria
Phase 2
Recruiting
- Conditions
- Chronic urticaria.Idiopathic urticaria
- Registration Number
- IRCT20110531006660N5
- Lead Sponsor
- Sari University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Chronic Idiopathic Urticaria
Age between 10 and 40 Years Old
Receiving Antihistamines
Patient Approval
Completion of Treatment for at least 30 Days
Exclusion Criteria
Concomitant illness; whether allergic or non-allergic ; Use of non-Antihistamine Medication
Age Less than 10 and above 40
Acute Hives
Physical Urticaria
Hypersensitivity or Antihistamine
Anaphylaxis
Pregnant Women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical resolution of urticaria. Timepoint: before and after treatment. Method of measurement: UAS7.;Thymic Stromal Lymphopoietin (TSLP). Timepoint: Before intervention and 3 months after intervention. Method of measurement: Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Enzyme-Linked Immunosorbent Assay (ELIZA).;Interferon Gama. Timepoint: Before intervention and 3 months after intervention. Method of measurement: RT-PCR ? ELIZA.;Interleukine4 (IL4). Timepoint: Before intervention and 3 months after intervention. Method of measurement: RT-PCR ? ELIZA.;IL35. Timepoint: Before intervention and 3 months after intervention. Method of measurement: RT-PCR ? ELIZA.;IL32. Timepoint: Before intervention and 3 months after intervention. Method of measurement: RT-PCR ? ELIZA.
- Secondary Outcome Measures
Name Time Method